Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Frontiers in Medicine
|
April 18, 2020
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
Joseph Meserve, Parambir Dulai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2019
Reply
David Faleck, Parambir Dulai, Ryan Ungaro
Pancreas
|
October 29, 2021
Quantifying the Risk of Drug-Induced Pancreatitis With Angiotensin-Converting Enzyme Inhibitors and Statins Using a Large Electronic Medical Record Database
Patrick A Twohig, Enrique de-Madaria, Shyam Thakkar, et al.
Alimentary Pharmacology & Therapeutics
|
March 21, 2021
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply
Sushrut Jangi, Hyuk Yoon, Parambir Dulai, et al.
Inflammatory Bowel Diseases
|
June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial
Dhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Eclinicalmedicine
|
December 11, 2024
Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials" volume 72, 102621
Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Eclinicalmedicine
|
May 10, 2024
Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials
Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Therapeutic Advances in Gastroenterology
|
April 29, 2025
Comment on "Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis"
Richard Kellermayer, Peter Lewindon, Cynthia Buness, et al.
Inflammatory Bowel Diseases
|
June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease
Christopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Pangenome comparison of <i>Bacteroides fragilis</i> genomospecies unveil genetic diversity and ecological insights
Renee E Oles, Marvic Carrillo Terrazas, Luke R Loomis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Frontiers in Medicine
|
April 18, 2020
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
Joseph Meserve, Parambir Dulai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2019
Reply
David Faleck, Parambir Dulai, Ryan Ungaro
Pancreas
|
October 29, 2021
Quantifying the Risk of Drug-Induced Pancreatitis With Angiotensin-Converting Enzyme Inhibitors and Statins Using a Large Electronic Medical Record Database
Patrick A Twohig, Enrique de-Madaria, Shyam Thakkar, et al.
Alimentary Pharmacology & Therapeutics
|
March 21, 2021
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply
Sushrut Jangi, Hyuk Yoon, Parambir Dulai, et al.
Inflammatory Bowel Diseases
|
June 30, 2025
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial
Dhruv Ahuja, Sama Anvari, Emily C L Wong, et al.
Eclinicalmedicine
|
December 11, 2024
Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials" volume 72, 102621
Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Eclinicalmedicine
|
May 10, 2024
Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials
Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Therapeutic Advances in Gastroenterology
|
April 29, 2025
Comment on "Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis"
Richard Kellermayer, Peter Lewindon, Cynthia Buness, et al.
Inflammatory Bowel Diseases
|
June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease
Christopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Pangenome comparison of <i>Bacteroides fragilis</i> genomospecies unveil genetic diversity and ecological insights
Renee E Oles, Marvic Carrillo Terrazas, Luke R Loomis, et al.
Page
of 2